Arquivos de Neuro-Psiquiatria · 2017 · 19 citations · 25 references
Life SciencesGeneticsNeurologyDementiaHuman GeneticsPrion DiseasesFamilial Prion DiseaseGenetic DisordersGerstmann-sträussler-scheinker DiseaseNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of Prion DiseaseCodon 129 PolymorphismDisease DurationFamilial Prion Disease PhenotypesGenetic Prion Protein MutationsGerstmann-sträussler-scheinker Disease NeuropathologyMutationNeuropathological ExaminationPolymorphisms At Codon 129
Gerstmann-Sträussler-Scheinker is a genetic prion disease and the most common mutation is p.Pro102Leu. We report clinical, molecular and neuropathological data of seven individuals, belonging to two unrelated Brazilian kindreds, carrying the p.Pro102Leu. Marked differences among patients were observed regarding age at onset, disease duration and clinical presentation. In the first kindred, two patients had rapidly progressive dementia and three exhibited predominantly ataxic phenotypes with variable ages of onset and disease duration. In this family, age at disease onset in the mother and daughter differed by 39 years. In the second kindred, different phenotypes were also reported and earlier ages of onset were associated with 129 heterozygosis. No differences were associated with apoE genotype. In these kindreds, the codon 129 polymorphism could not explain the clinical variability and 129 heterozygosis was associated with earlier disease onset. Neuropathological examination in two patients confirmed the presence of typical plaques and PrPsc immunopositivity.
25
Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome
Karen Hsiao, Harry F. Baker, Tim Crow et al. · Nature · 1989 · 847 citations
Genetic prion disease: the EUROCJD experience
Gábor G. Kovács, Maria Puopolo, Anna Ladogana et al. · Human Genetics · 2005 · 448 citations
Mortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada
Anna Ladogana, Maria Puopolo, Esther A. Croes et al. · Neurology · 2005 · 382 citations
Medicine, Oncology, Pharmacology +17
Katsumi Doh‐ura, Jun Tateishi, Hiroyuki Sasaki et al. · Biochemical and Biophysical Research Communications · 1989 · 265 citations